GRADE Concept Paper 1: Validating the "FACE" instrument using stakeholder perceptions of feasibility, acceptability, cost, and equity in guideline implement
Por:
Pottie, K, Magwood, O, Rahman, P, Concannon, T, Alonso-Coello, P, Garcia, AJ, Santesso, N, Thombs, B, Welch, V, Wells, GA, Saad, A, Archibald, D, Grad, R, Moore, A, Rojas, MX, Iorio, A, Pinto, N, Doull, M, Morton, R, Akl, EA, Schunemann, HJ, Tugwell, P
Publicada:
1 mar 2021
Resumen:
Background and objective: To present a structured approach for assessing stakeholder perceptions and implementing the approach in guideline development.
Methods: This work was carried out by the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) Equity and Stakeholder Engagement Project Groups through brainstorming and iterative frameworks, stakeholder engagement, pilot testing, refinement of ideas, using input from workshops, and discussions at GRADE Working Group meetings to produce this document, which constitutes a GRADE conceptual article on implementation.
Results: We introduce the FACE implementation criteria, feasibility, acceptability, cost, and equity; priority; and "intent to implement" criterion. We outline the implementation importance of networks and approaches to patient and other stakeholder engagement. Implementation is often highly contextual and can benefit from stakeholder engagement and other assessments. Our FACE approach provides stakeholder questions and language to inform guideline implementation and tools.
Conclusion: The FACE criteria propose a series of knowledge translation questions to guide the assessment of implementation for evidence-based guidelines. It is desirable for guideline developers to use a conceptual approach, such as FACE, to tailor implementation and inform end of guideline dissemination and knowledge translation activities. (C) 2020 Published by Elsevier Inc.
Filiaciones:
Pottie, K:
Bruyere Res Inst, CT Lamont Primary Hlth Care Res Ctr, Ottawa, ON, Canada
Univ Ottawa, Sch Epidemiol & Publ Hlth, Dept Family Med, Ottawa, ON, Canada
Magwood, O:
Bruyere Res Inst, CT Lamont Primary Hlth Care Res Ctr, Ottawa, ON, Canada
Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada
Rahman, P:
Publ Hlth Agcy Canada, Ottawa, ON, Canada
Concannon, T:
RAND Corp, Boston, MA USA
Alonso-Coello, P:
Inst Invest Biomed St Pau IIB St Pau CIBERESP, Iberoamer Cochrane Ctr, Barcelona, Spain
Garcia, AJ:
Publ Hlth Agcy Canada, Ottawa, ON, Canada
Santesso, N:
McMaster Univ, Fac Hlth Sci, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
Thombs, B:
McGill Univ, Dept Psychol, Montreal, PQ, Canada
Welch, V:
Bruyere Res Inst, Ctr Global Hlth, Ottawa, ON, Canada
Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada
Wells, GA:
Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa Heart Inst, Ottawa, ON, Canada
Saad, A:
Bruyere Res Inst, CT Lamont Primary Hlth Care Res Ctr, Ottawa, ON, Canada
Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada
Archibald, D:
Bruyere Res Inst, CT Lamont Primary Hlth Care Res Ctr, Ottawa, ON, Canada
Univ Ottawa, Dept Family Med, Ottawa, ON, Canada
Grad, R:
McGill Univ, Dept Family Med, Montreal, PQ, Canada
Moore, A:
McMaster Univ, Dept Family Med, Hamilton, ON, Canada
Rojas, MX:
Pontificia Univ Javeriana, Dept Clin Epidemiol & Biostat, Bogota, Colombia
Iorio, A:
McMaster Univ, Fac Hlth Sci, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
Pinto, N:
Bruyere Res Inst, Ottawa, ON, Canada
Doull, M:
Publ Hlth Agcy Canada, Ottawa, ON, Canada
Morton, R:
Univ Sydney, Fac Med & Hlth, NHMRC Clin Trials Ctr, Sydney, NSW, Australia
Akl, EA:
Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon
Schunemann, HJ:
McMaster Univ, Fac Hlth Sci, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
Tugwell, P:
Univ Ottawa, Dept Family Med, Ottawa, ON, Canada
|